HeartFlow, Inc. (HTFL)
Market Closed
10 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
45. 49
-1.18
-2.5284%
Pre Market
$
+0.4 +0.8793% 45. 89
4.22B Market Cap
- P/E Ratio
- Div Yield
1.56M Volume
- Eps
$ 46.67
Previous Close Want to track HTFL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
HTFL closed today lower at $45.49, a decrease of -2.5284% from yesterday's close, completing a monthly increase of 75.5015% or $19.57. Over the past 12 months, HTFL stock gained 54.9915%.
HTFL is not paying dividends to its shareholders.
The last earnings report, released on Mar 18, 2026, exceeded the consensus estimates by 0.1683%. On average, the company has surpassed earnings expectations by 0.1694%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High
The sale of 33,416 shares generated a total value of approximately $1.7 million based on a weighted average execution price of $49.85. The traded shares represent 13% of the equity stake held by the officer before the transaction.
Fool | 5 days ago
HeartFlow: An Impressive MedTech Growth Play
HeartFlow delivered a convincing Q2 with 48% sales growth and gross margins rising to 83%, driving strong market optimism. The company raised full-year revenue guidance to $246–$250 million, though the outlook appears conservative given recent momentum and sequential growth. Shares now trade at 13x sales, supported by accelerating topline growth, expanding plaque-related revenue, and commercial adoption of its non-invasive cardiac solution.
Seekingalpha | 3 weeks ago
HeartFlow, Inc. (HTFL) Q2 2026 Earnings Call Transcript
HeartFlow, Inc. (HTFL) Q2 2026 Earnings Call Transcript
Seekingalpha | 4 weeks ago
HeartFlow, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 100 | $2,433 | $4,584 | $2,151 | 88.41% |
| BG Bart Gancher Intech Investment Management LLC | 16,384 | $480,706.56 | $472,186.88 | -$8,519.68 | -1.77% |
| GN Gina Nelson Next Century Growth Investors LLC | 671,404 | $16.43M | $28.27M | $11.85M | 72.11% |
| JM John Malone Amundi | 12,278 | $360,236.52 | $360,359.3 | $122.78 | 0.03% |
 Point72 Asset Management LP Point72 Asset Management LP | 1.72M | $50.18M | $72.43M | $22.25M | 44.35% |
HeartFlow, Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| MO Matt OBrien Piper Sandler | 2,488.42 | $104,712.78 | $113,123.64 | $8,410.86 | 8.03% |
HeartFlow, Inc. (HTFL) FAQ
What is the stock price today?
The current price is $45.49.
On which exchange is it traded?
HeartFlow, Inc. is listed on NASDAQ (NMS).
What is its stock symbol?
The ticker symbol is HTFL.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 4.22B.
Has HeartFlow, Inc. ever had a stock split?
No, there has never been a stock split.
HeartFlow, Inc. Profile
| Health Care Technology Industry | Healthcare Sector | John Farquhar CEO | NASDAQ (NMS) Exchange | 42238D107 CUSIP |
| US Country | 843 Employees | - Last Dividend | - Last Split | - IPO Date |
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
Contact Information
Address: 135 Main Street
Phone: 650-241-1221
Website: https://www.heartflow.com
